Department of Health and Human Services July 26, 2010 – Federal Register Recent Federal Regulation Documents
Results 1 - 9 of 9
Medicare and Medicaid Programs; Application by Det Norske Veritas Healthcare for Deeming Authority for Critical Access Hospitals (CAHs)
This proposed notice with comment period acknowledges the receipt of an application from Det Norske Veritas Healthcare (DNVHC) for recognition as a national accrediting organization for critical access hospitals (CAHs) that wish to participate in the Medicare or Medicaid programs.
Seeking Public Comment on Draft National Health Security Strategy Biennial Implementation Plan
To help the Nation achieve national health security and to implement the first quadrennial National Health Security Strategy (NHSS) of the United States of America (2009) and build upon the NHSS Interim Implementation Guide for the National Health Security Strategy of the United States of America (2009) the U.S. Government has drafted a NHSS Biennial Implementation Plan (BIP). This document is intended to describe the priority activities to occur during fiscal years 2011 and 2012 of implementation so that all sectors and segments of the Nation are working collectively and leveraging resources to achieve the same outcomes. The activities include responsible entities, timelines and measures. The target audience for the BIP is the Nation (individuals, families, communities including all sectors and governments, states and the Federal Government). It also outlines a framework for evaluation of impact of the NHSS.
Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee-September 22, 2010
This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) (``Committee'') will be held on Wednesday, September 22, 2010. The Committee generally provides advice and recommendations concerning the adequacy of scientific evidence needed to determine whether certain medical items and services can be covered under the Medicare statute. This meeting will focus on the currently available evidence regarding the clinical benefits and harms of on-label and off-label use of bone morphogenetic proteins (BMPs). This meeting is open to the public in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.